Compugen (CGEN) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Compugen (CGEN) PT Lowered to $14 at Truist Securities
February 25, 2022 6:36 AM ESTTruist Securities analyst Asthika Goonewardene lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Following the EPS call and our discussion with mgmt, we are adjusting our model to reflect a slower route... More
Compugen (CGEN) PT Lowered to $14 at Stifel
February 24, 2022 12:17 PM ESTStifel analyst Stephen Willey lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Management continues to make progress on the various dose expansion cohorts comprising the P1/2 development program evaluating various COM701-based combinations... More
